A股異動 | 衞星化學漲5% 擬以150億元新建綠色化學新材料產業園項目
格隆匯12月30日丨衞星化學(002648.SZ)漲5.65%,報41.84元,總市值720億元。衞星化學12月29日發佈公吿,公司擬在連雲港徐圩新區投資新建綠色化學新材料產業園項目,總投資含税約150億元,建設內容主要包括年產20萬噸乙醇胺、年產80萬噸聚苯乙烯、年產10萬噸α-烯烴與配套POE、年產75萬噸碳酸酯系列生產裝置及相關配套工程,共分三期進行分步實施。項目計劃於2022年3月30日前開工建設。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.